Empress Therapeutics co-founders from L-R: John Mendlein, Sabrina Yang, Jason Park, and Doug Cole.
Flagship startup Empress Therapeutics launches to search for small molecule drug leads in microbial DNA
Flagship’s latest startup is betting that a treasure trove of small molecule drugs is waiting to be discovered right inside our bodies — or rather, inside …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
